Evidence synthesis
Organize scientific literature into traceable disease, mechanism, and target context.
Q-RETIX AI explores evidence-aware language models for therapeutic target discovery—connecting literature, biological mechanisms, and multi-omic context to produce clearer, testable research hypotheses.
Concept workflow
Therapeutic target reasoning

Input
Multi-source evidence
Output
Testable hypotheses
Evidence mapping
Literature + biology
Target reasoning
Mechanism + novelty
Validation planning
Human-reviewed next steps
Research focus
Q-RETIX is being developed as a research decision-support layer. The goal is not to replace scientists, but to make complex biological reasoning more structured, inspectable, and useful.
Organize scientific literature into traceable disease, mechanism, and target context.
Connect genes, proteins, pathways, phenotypes, and disease drivers without treating them as interchangeable.
Reason across genomic, transcriptomic, proteomic, and metabolic signals when relevant data is available.
Compare novelty, causal relevance, tractability, uncertainty, and supporting evidence.
Translate computational hypotheses into explicit experiments, controls, and falsifiable next steps.
Separate known evidence, supported inference, and hypothesis for clearer scientific review.
Research workflow
This is the target operating model for Q-RETIX research—not a claim of completed clinical, regulatory, or commercial milestones.
Set the disease scope, decision criteria, exclusions, and the evidence required to support a useful answer.
Review relevant sources and distinguish reported findings from gaps, disagreements, and missing data.
Structure relationships across disease drivers, regulatory nodes, pathways, phenotypes, and intervention points.
Rank candidates using explicit criteria such as biological relevance, novelty, tractability, and uncertainty.
Propose experiments, controls, readouts, failure conditions, and evidence that would change the conclusion.
Apply expert review, document limitations, and present conclusions as evidence, inference, or hypothesis.
Explore computational research notes on target discovery, disease biology, and responsible AI-assisted scientific reasoning.
Research hypotheses · Independent validation required
Generative BiologyHow an LLM-driven target-prioritization pipeline surfaced PGC1A as a biologically plausible, disease-modifying research hypothesis for COPD.
Read article
ResearchHow Q-RETIX AI Identified SREBF1 as a Systems-Level Therapeutic Target for Type 2 Diabetes
Read article
ResearchHow Structural AI Bypassed the Electrostatic Charge Trap to Reignite a Dormant Therapeutic Target.
Read articleScientific standards
Q-RETIX communicates research-stage work with explicit limitations. These principles guide how computational findings should be interpreted and reviewed.
Claims should be traceable to primary evidence wherever possible—not justified by confident language alone.
Unknowns, conflicts, weak evidence, and model limitations should be surfaced instead of hidden.
Qualified researchers remain responsible for checking sources, interpreting context, and approving next steps.
Computational output is hypothesis generation. Laboratory, safety, ethics, clinical, and regulatory review remain essential.
Target rankings, mechanisms, and model narratives require independent scientific and experimental validation.
Receive occasional Q-RETIX research articles, transparent product progress, and opportunities to contribute feedback.
New articles, methods, and scientific explainers.
Transparent updates as research concepts become prototypes.
Occasional invitations to feedback sessions or beta access.
Join the list
This website does not yet use an automated subscription backend. Use your own email app to request research updates; Q-RETIX receives information only after you choose to send the message.
No personal information is collected by this page. Your email provider handles the message you decide to send. Read the Privacy Policy.
Prefer a direct conversation?
Meet Q-RETIX